Non-Executive Director Nadeem Amjad sold 2,000,000 shares at Rs 85.50, reducing cumulative holding to 22,106,895 shares (9.67%) (CPHL)
Filed as: Insider Transaction
Summary
Non-Executive Director Nadeem Amjad sold 2,000,000 shares at Rs 85.50, reducing cumulative holding to 22,106,895 shares (9.67%). Executive Director Rizwan Ahmad bought 2,000,000 shares at Rs 85.50, increasing cumulative holding to 53,929,752 shares (23.60%).
Read the original filingTransactions disclosed
| Person | Transaction | Shares | Price | Date |
|---|---|---|---|---|
| Nadeem AmjadNon-Executive Director | SellReady market | 2,000,000 | Rs 85.50 | 22 Apr 2026 |
| Rizwan AhmadExecutive Director | BuyReady market | 2,000,000 | Rs 85.50 | 22 Apr 2026 |
As disclosed by the company. A purchase or sale by an insider is a fact about that person's holding, not a signal about the share.
Citi Pharma Ltd. (CPHL) on Nafa
Last price Rs 64.00 · Pharmaceuticals · You can own CPHL shares from your phone.
More CPHL announcements
- NoticeTransmission of Quarterly Report for the Period Ended 30 September 2026
- Financial resultCiti Pharma Limited reported a net profit of Rs 233.23 million for the period ended September 30, 2026Filed as: Financial Results for the Quarter Ended 30 September 2026
- NoticeBoard Meeting In Progress
- Material informationCiti Pharma Acquires 20% of Pakheim InternationalCiti Pharma Limited acquires 20% shareholding in Pakheim International Pharma, marking the first step towards full acquisition.
- NoticeCertified true copy of the resolutions passed in the Annual General Meeting of the Company
- NoticeChange of Chief Financial Officer
Source: Citi Pharma Ltd.'s filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.